Secretary Azar, Gov. Charlie Baker, Lt. Gov Polito, and Mass HHS Secretary Sudders visit to BIDMC
Governor Charlie Baker, Lt. Governor Karyn Polito and U.S. Secretary of Health and Human Services Alex Azar joined Dr. Barouch for an important discussion about our COVID-19 vaccine response. For more about their BIDMC visit, click here.
Medical All-Stars
The Boston Red Sox honored Dr.Stephenson on June 7th,2019 as a Medical All-Star for her work in the HIV research field.
2019 CVVR Visiting Professor
We were honored to have Dr. Robert Siliciano, MD, PhD. join us for our annual visiting professor this year.
2019 Boston Pride Parade
Members of CVVR joined Team BIDMC for the 2019 Boston Pride Parade.
2019 Boston AIDS Walk
Members of the CVVR joined TEAM BIDMC for the 2019 Aids Walk, which is the largest HIV/AIDS awareness event in New England.
Conference on Retrovirus and Opportunistic Infections 2019
“The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2019 will be held from March 4 to March 7, 2019, at the Washington State Convention Center in Seattle, Washington.”
Biden administration to begin rolling out booster shots the week of Sept. 20
/0 Comments/in News /by Morgana SouzaHealth care workers and nursing home residents are first in line Read Article
What to Know About Boosters if You Got the Johnson & Johnson Vaccine
/0 Comments/in News /by Morgana SouzaHealth experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks. Read Article
F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systems
/0 Comments/in News /by Morgana SouzaThe decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised. Read Article
Dan Barouch and the birth of the J&J COVID vaccine
/0 Comments/in News /by Morgana SouzaDan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of three vaccines against COVID-19 approved for use in the U.S. Read Article
New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
/0 Comments/in News /by Morgana Souza“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in Boston who has led some studies for J. & J. Read Article
J&J Vaccine Highly Effective Against Delta Variant in South African Trial
/0 Comments/in News /by Morgana SouzaStudy finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
/0 Comments/in News /by Morgana Souza“The more breakthroughs you have, the easier it is to determine,” Katy Stephenson. Read Article
Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
/0 Comments/in News /by Morgana SouzaDan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health solely and not on economic incentives of the companies. Read Article
Johnson & Johnson Vaccine Protects Against Delta Variant Of COVID, Study Finds
/0 Comments/in News /by Morgana SouzaThe Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find
/0 Comments/in News /by Morgana SouzaThe Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in a statement Thursday night. Read Article